I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease
This study is a Phase 3, randomized, double-blind, placebo-controlled study of voxelotor in pediatric participants, aged 2 to < 15 years old, with Sickle Cell Disease. The primary objective is to evaluate the effect of voxelotor on the TCD (Transcranial Doppler Ultrasound) measurements in SCD participants in this age range.
cerebral blood flow
transcranial doppler ultrasonography
gbt440
anemia
pediatric
- 0 views
- 19 Feb, 2024